ARTICLE | Clinical News
EchoGen Emulsion: Began a Phase III trial
January 2, 1996 8:00 AM UTC
Blinded readers will evaluate the ability of EchoGen to opacify (fill) the left ventricle and improve delineation of the endocardial border in patients with sub-optimal echocardiograms who are undergo...